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Background: Given that impairment of fear extinction has been implicated in the pathogenesis of posttraumatic
stress disorder (PTSD), effective pharmacological interventions that facilitate fear extinction may provide alternative
strategies to conventional treatment. It is generally accepted that the zeta inhibitory peptide (ZIP), a controversial
inhibitor of protein kinase M zeta (PKMζ), could erase certain types of previously established long-term memories.
However, it is unclear whether ZIP administration may alleviate PTSD-associated depressive and anxiety-like
abnormalities.
Methods: Here we developed a re-stressed single-prolonged stress (SPS) paradigm, a modified prevalent animal
model of PTSD, and assayed the expressions of PKMζ in the hippocampus after SPS procedure. Next, Seven days
prior to re-stress, ZIP was injected into the hippocampus, and the depressive and anxiety-like behavior was
examined by the subsequent forced swim (FS), open-field and elevated plus maze (EPM) test.
Results: Rats given ZIP prior to FS exhibited a reduction of immobility time in FS test, and more open arms (OA)
entries and longer OA duration in EPM. They also spent longer time in the center of the open field.
Conclusions: Our results suggested that re-stressed SPS could reproduce behavioral alteration similar to that
observed in patients with PTSD, and these behavioral symptoms co-morbid with PTSD could be effectively
alleviated by the intro-hippocampal administration of ZIP.
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Posttraumatic stress disorder (PTSD) can develop fol-
lowing exposure to a severe traumatic event or natural
disasters [1]. It is a psychopathological response to the
traumatic stressor and is characterized by intense
memories in which patients re-experience their original
traumatic experiences, as well as avoidance of the trauma-
related stimuli, and increased arousal [2,3]. However, the
precise mechanism of the intricate biological and psy-
chological symptom remains elusive. The neural struc-
tures involved in the pathophysiology of PTSD belong to
the limbic system, a region important for emotional pro-
cessing in both humans and animals [4]. The three brain* Correspondence: zywang@live.cn
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unless otherwise stated.regions within the limbic system most clearly altered in
PTSD have been identified as the prefrontal cortex, the
amygdala and the hippocampus, among which, the hippo-
campus plays a key role in explicit memories of traumatic
events and in mediating learned responses to contextual
cues [5-8]. Indeed, hippocampal reduction has been found
in patients with PTSD in a majority of structural neuroim-
aging studies [9-13].
Single-prolonged stress (SPS), a currently prevalent
animal model of PTSD, has been extensively developed
and employed in the investigation of PTSD [14-16]. SPS
consists of three different stress paradigms: restraint for
2 h, forced swim for 20 min, and ether anesthesia. SPS
exposure results in impaired extinction of contextual
fear [16], enhanced glucocorticoid negative feedback,
and enhanced anxiety-like behavior [17,18], partiallyhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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malities of PTSD [19].
The persistence of traumatic fear memories in PTSD
suggests this disorder might be associated with extinction
deficits [20-23], consistent with an interpretation of PTSD
as a syndrome of deficient extinction ability [24]. Thus,
any intervention facilitating fear extinction or disrupting
fear memory may have a therapeutic value on PTSD. Over
the past two decades, multiple lines of evidence have indi-
cated that protein kinase M zeta (PKMζ), a brain-specific
atypical protein kinase C (PKC) isoform, is required for
long term potentiation (LTP) and the maintenance of
several forms of memory, including the hippocampus-
dependent memory [25-31]. Overexpression of PKMζ
could enhance long-term memory, while pharmacologi-
cally blocking PKMζ by myristoylated zeta-pseudosubstrate
inhibitory peptide (ZIP) could erase previously established
long-term memories [26,28,32-35]. Although currently
there is still an ongoing debate on the critical issue of
PKMζ being a major memory maintenance molecule and
ZIP as a specific PKMζ inhibitor [34,36-40], there is a con-
sensus among researchers that ZIP can disrupt certain
types of memory [29,30,33,34,37,41]. Thus the mechanism
of ZIP on memory disruption is far from clear. Neverthe-
less, PKMζ remains largely to be the target of ZIP infu-
sions [42]. These inconsistent findings open up a variety
of opportunities to gain additional insight into the action
of ZIP.
As mentioned above, most research on ZIP has been ap-
plied to a certain kind of conditioned learning and mem-
ory paradigm to investigate its role on memory disruption.
Since SPS has been shown to disrupt the retention stage
of fear extinction [20], it is interesting to know whether
ZIP may have an impact on SPS procedure, especially the
depressive and anxiety-like behavior, representing the core
symptom of PTSD-related abnormalities. As a result, the
present study used a classic SPS model, but after the last
quiescent period, the rats were re-exposed to the forced
swim component of SPS, which served as the re-stress
component of the paradigm. Next, the expression of
PKMζ in the hippocampus of SPS rats was assayed. Fi-
nally, ZIP was microinfused into the hippocampus seven
days prior to re-stress, and subsequent forced swim, open-
field and elevated plus maze test were performed, so as to
assess the effect of ZIP on the PTSD-associated symptoms
of depressive and anxiety-like behavior.
Materials and methods
Animals
Male Sprague-Dawley rats (7 - 8 weeks old) weighing 200
- 250 g were purchased from the Experimental Animal
Center of China Medical University (Shenyang, China).
Animals were housed singly under a 12:12-h light dark
cycle, with food and water freely available. Following anadaptation period of at least 7 days, the experimental pro-
cedures were undertaken. All procedures complied with
the National Institutes of Health Guide for the care and
use of laboratory animals and were approved by the
Animal Care and Use Committee of China Medical
University.
Experimental groups and the SPS model
The rats were randomly assigned to seven groups
(Control, SPS 7d, SPS 14d, Control + Saline, Control +
ZIP, SPS + Saline, and SPS + ZIP, 12 rats per group). The
SPS procedure was conducted as described previously
[1,17], with slight modifications. Briefly, Rats were
restrained for 2 h inside a disposable restraint holder
(diameter 58 mm, length 150 mm). Next, they were in-
dividually placed in a clear acrylic container (600 ×
400 × 500 mm) filled two thirds with water (24°C), and
forced to swim for 20 min. Following a 15-min recuper-
ation, animals were exposed to diethyl ether until loss of
consciousness and left undisturbed in their cages for 7
or 14 days according to their groups (Figure 1).
Surgery
Rats were anaesthetized with chloral hydrate (400 mg/kg i.p)
and prepared with bilateral stainless steel 26-gauge cannulae
aimed at the dorsal hippocampus using stereotaxic coordi-
nates (anteroposterior, −3.6 mm; medial-lateral, ± 3.1 mm;
dorsoventral, −2.4 mm) relative to bregma. Cannulae were
secured to the skull with stainless steel screws and dental ce-
ment. Stainless steel obdurators remained in the cannulae
when rats were not being injected to prevent occlusion.
Each rat was given a recovery period of at least 7 d before
the experiments.
Drug infusions
ZIP (Abcam, Cambridge, MA, USA) was dissolved in
sterile saline to a concentration of 10 nmol/μl. ZIP or sa-
line were infused into the dorsal hippocampus (1 μl per
hemisphere) via a microinjector (28 gauge) connected to
a microinfusion pump (Stoelting Co., Wood Dale, IL,
USA) at a rate of 0.25 μl per min. The injector remained
connected for an additional 1 min to allow for drug dif-
fusion away from the tip of the cannula.
Forced swim test (FST)
Rats were individually forced to swim in an open cylin-
drical container (diameter 20 cm, height 40 cm) filled to
two-thirds with 24°C fresh water. The total duration of
immobility during the 5-min test was scored by a trained
individual blinded to the experimental group. Each
mouse was judged to be immobile when it ceased strug-
gling and remained floating motionless in the water,
making only those movements necessary to keep its
head above water.
Figure 1 Schematic of experimental design. Rats were exposed to control handling or SPS, followed by 7 or 14 days of quiescent period with
no manipulation. Next, for the Control, SPS 7d and SPS 14d groups, subsequent forced swim (FS), open-field (OF) and elevated plus maze (EPM)
test were performed, and the rats were finally sacrificed for Western blotting and real-time RT-PCR. For the Control + Saline, Control + ZIP, SPS +
Saline, and SPS + ZIP groups, ZIP or saline were administrated after the 7 days of quiescent period of SPS. Following another 7 days interval, FS,
OF and EPM were performed.
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The open-field test was used to quantify locomotor,
exploratory and anxiety-like behavior. The apparatus
was a black Plexiglas enclosure measuring 50 × 50 × 50
cm with a red fluorescent light illumination over the
center of the arena. After 30 min of acclimation in the
room, rats were placed in a central start position in the
open arena and allowed to explore for 5 min, during
which their behavior was recorded and analyzed with
“SuperMaze” software (Softmaze Co., Shanghai, China).
The arena was cleaned with 70% ethanol after each ses-
sion and individual rat was tested only once.
The elevated plus maze (EPM)
The EPM apparatus consisted of two opposing open and
two opposing closed arms (50-cm arms, elevated 50 cm
off the ground). Animals were placed into the center
(10 × 10 cm) of the maze facing an open arm and beha-
vior was recorded for 5 min. The number of arm entries
and time spent in open and closed arms were analyzed
with “SuperMaze” software (Softmaze Co.). The percen-
tage of time spent in the open arms and percentage of
entries into the open arms relative to total (open +
closed) arm were quantified as assessments of anxiety.
Western blot analysis
The rats of each group were decapitated rapidly and the
hippocampi were dissected on ice. The samples were ho-




GAPDH 5’-ACATGGTCTACATGTTCC-3’buffered saline, 4% sodium dodecyl sulfate, 20% glycerol
and 10% 2-mercaptoethanol, and were denatured by boil-
ing for 3 min. The protein fraction (30 μg/lane) extracted
from each sample was separated by 12% (w/v) gradient so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis
and transferred to a 0.45-μm polyvinylidene fluoride
(PVDF) membrane (Millipore, Billerica, MA, USA). Fol-
lowing blocking with 5% (w/v) skimmed milk in 0.05%
TBS with Tween-20 (TBST) at room temperature for 2 h
and incubation with a rabbit polyclonal antibody against
rabbit polyclonal antibody against PKC (1:5000; Abcam,
Cambridge, MA, USA) overnight at 4°C, the membrane
was incubated with anti-rabbit IgG-HRP (1:5000; ZSBio,
Beijing, China) secondary antibodies for another 2 h at
room temperature. Blots were scanned with a ChemiDoc
XRS + image analysis system (Bio-Rad Laboratories,
Hercules, CA, USA) and analyzed with ImageJ software
(National Institutes of Health, Bethesda, MD, USA).
mRNA extraction and quantitative real-time RT-PCR
analysis
For detecting the mRNA levels of PKMζ and PKCζ, quan-
titative real-time RT-PCR was conducted. Total RNA
from dissected hippocampus was isolated with TRIzol
(Invitrogen, Carlsbad, CA, USA) according to the manu-
facturer's instructions. The primer sequences (designed
and synthesized by Sangon Biotech Co., Shanghai, China)
were presented in Table 1. Complementary DNA (cDNA)





Figure 2 Comparison of immobility time in the forced swim
test. Data are expressed as mean ± S.E.M. with 12 rats per group. The
animals in SPS 7d group or SPS 14d group spent a significantly longer
percentage of immobile time (immobile time%) compared with the
control group (p < 0.001, respectively) (A). The microinjection of ZIP
to the hippocampus resulted in reduced percentage of immobile
time in the SPS + ZIP group compared with the ZIP + Saline group
(p < 0.001) (B).
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quantitative PCR analysis was performed on the ABI 7500
Real-time PCR System (Applied Biosystems Inc., Foster
City, CA, USA), using SYBR® Premix Ex Taq™ kit (TaKaRa
Biotech). Triplicate reactions were run per sample. Rela-
tive quantification of gene expression was determined
based on the threshold cycle (Ct) value for each PCR reac-
tion. ΔCt values represent normalized target gene levels
with respect to the internal control (GAPDH). Relative
quantification of gene expression (relative amount of
target RNA) was determined by the 2-ΔCt method. ΔΔCt
values were calculated as the ΔCt of each sample minus
the mean ΔCt of the calibrator samples (control group).
The fold change in expression was calculated with the
equation 2-ΔΔCt. All primer sets had comparable efficiency
of amplification. After amplification, the specificity of the
PCR products was verified by a melting curve analysis to
ensure that a single product of expected melt curve cha-
racteristics was obtained.
Statistical analysis
All data were presented as mean ± S.E.M. unless other-
wise specified, and were analyzed with SPSS software
(version 20.0; IBM, Armonk, NY, USA) and SigmaPlot
(version 12.3; Systat Software Inc., San Jose, CA, USA).
Data were analyzed via one-way ANOVA or two-way
ANOVA, followed by Tukey’s post hoc test or unpaired
Student’s t test when appropriate. Significant differences
between groups were defined by a p value less than 0.05.
Results
Effect of ZIP on forced swim behavior following the SPS
procedure
To examine the effects of re-exposure to the traumatic
stress, seven or fourteen days after SPS stressors were
applied, rats were re-stressed by re-exposure to the
forced swim component of SPS, and they exhibited en-
hanced depressive-like behavior evaluated by immobility
time in 5-min FST (Figure 2A. Immobility Time (s):
Control group 103.3 ± 15.57; SPS 7d group 157.1 ± 20.22;
SPS 14d group 153.2 ± 15.85). One-way ANOVA showed
significant differences among the groups in immobility
time (F (2, 33) = 35.91, p < 0.001). Tukey’s post hoc ana-
lysis revealed that the animals in SPS 7d group or SPS
14d group spent a significantly longer percentage of time
immobile compared with the control group (p < 0.001,
respectively). There was no significant difference in the
immobility time between the two SPS-exposed groups
(p = 0.849).
Next, the PKMζ inhibitory peptide (ZIP) was microin-
fused into the bilateral dorsal hippocampi after the seven
undisturbed days for SPS and the animals were left un-
disturbed for another seven days until the FST was car-
ried out (Figure 2B. Immobility Time (s): Control +Saline group 113.4 ± 4.98; Control + ZIP group 106.5 ±
3.55; SPS + Saline group 165.7 ± 4.98; SPS + ZIP group
125.3 ± 4.51). Two-way ANOVA showed significant effects
of SPS (F (1, 44) = 61.185, p < 0.001), ZIP (F (1, 44) =
27.117, p < 0.001), and interaction between SPS and ZIP
(F (1, 44) = 13.562, p < 0.001) . Tukey’s post hoc analysis
revealed that the percentage of immobile time in the
SPS + ZIP group was shorter than that in the SPS + Saline
group (p < 0.001). There was no significant difference in
the percentage of immobile time between the SPS + ZIP
and Control + Saline groups (t (22) = 1.764, p = 0.091).
Effect of ZIP on anxiety-like behavior
Open field test was performed 1 day after FST to exa-
mine anxiety-like behavior and locomotion. One-way
ANOVA showed significant differences in time in center
(F (2, 33) = 5.961, p = 0.006) and distance in center (F (2,
33) = 5.776, p = 0.007) among the groups (Figure 3A, B.
Figure 3 Effect of ZIP on behavior in the open field test. Time in the center (A and D), distance in the central area (B and E), and total
distance (C and F). Data are expressed as mean ± S.E.M. with 12 rats per group.
Ji et al. Behavioral and Brain Functions 2014, 10:28 Page 5 of 10
http://www.behavioralandbrainfunctions.com/content/10/1/28Time in center (s): Control group 8.5 ± 0.45; SPS 7d
group 6.2 ± 0.59; SPS 14d group 6.6 ± 0.45. Distance in
center (cm): Control group 38.47 ± 2.017; SPS 7d group
29.61 ± 2.582; SPS 14d group 28.76 ± 2.069). Post hoc
comparison revealed that both the SPS 7d group and the
SPS 14d group spent significantly less time in the center
than the control group (p = 0.007, p = 0.032, respectively)
and covered less distance in the center (p = 0.012,
p = 0.023, respectively). There was no difference between
the SPS 7d group and the SPS 14d group (p > 0.05). As
for the total distance covered, one-way ANOVA did not
reveal a significant difference among the three groups
(F (2, 33) = 0.505, p = 0.608), suggesting that SPS expo-
sure did not affect gross motoric behavior (Figure 3C).
Next we examined whether the ZIP microinjection
could alleviate the anxiety-like behavior evaluated by OFT
in rats subjected to SPS. Two-way ANOVA showed
significant effects of SPS (F (1, 44) = 11.772, p < 0.001;
F (1, 44) = 13.699, p < 0.001), ZIP (F (1, 44) = 0.770,
p = 0.385; F (1, 44) = 5.743, p = 0.021), and interaction bet-
ween SPS and ZIP (F (1, 44) = 7.877, p = 0.007; F (1, 44) =
2.638, p = 0.111) in time and distance in the center
(Figure 3D, E. Time in center (s): Control + Saline group
8.5 ± 0.46; Control + ZIP group 7.8 ± 0.33; SPS + Saline
group 6.2 ± 0.36; SPS + ZIP group 7.6 ± 0.26. Distance in
center (cm): Control + Saline group 36.18 ± 1.913; Con-
trol + ZIP group 37.38 ± 1.441; SPS + Saline group 27.84 ±
1.591; SPS + ZIP group 34.13 ± 1.236). Tukey’s post hoc
analysis revealed that the time in the center in the SPS +
ZIP group was higher than that in the SPS + Saline group(p = 0.013) , and the distance in the center in the SPS +
ZIP group was more than that in the SPS + Saline group
(p = 0.007), indicative of lower anxiety. There were no sig-
nificant differences in the total distance (SPS: F (1, 44) =
1.154, p = 0.289; ZIP: F (1, 44) = 1.365, p = 0.249; inter-
action between SPS and ZIP: F (1, 44) = 0.0001, p = 0.992)
(Figure 3F).
One hour after OFT, the elevated plus maze test was
applied. One-way ANOVA showed significant differences
in the percentage of open arm time (F (2, 33) = 277.775,
p < 0.001) and the percentage of open arm entries (F (2,
33) = 44.922, p < 0.001) among the groups (Figure 4A, B.
Open Arm Time (s): Control group 52.3 ± 1.33; SPS 7d
group 20.7 ± 0.91; SPS 14d group 21.2 ± 0.97. Open Arm
Entries: Control group 1.25 ± 0.18; SPS 7d group 0.67 ±
0.14; SPS 14d group 0.83 ± 0.17). Post hoc comparison
revealed that exposure of rats to SPS led to a reduction
in OA duration and OA entries in both the SPS 7d
(p < 0.001, respectively) and SPS 14d groups (p < 0.001,
respectively) compared with the unstressed control, indi-
cating an increased anxiety behavior.
After ZIP injection, two-way ANOVA showed sig-
nificant effects of SPS (F (1, 44) = 166.766, p < 0.001;
F (1, 44) = 42.666, p < 0.001), ZIP (F (1, 44) = 119.016,
p < 0.001; F (1, 44) = 11.926, p = 0.001), and interaction
between SPS and ZIP (F (1, 44) = 93.678, p < 0.001; F (1,
44) = 7.805, p = 0.008) on the percentage of time spent in
the open arms and the percentage of open arm entries
(Figure 4C, D. Open Arm Time (s): Control + Saline
group 53.3 ± 1.21; Control + ZIP group 55.0 ± 1.37;
Figure 4 Comparisons of the percentage of time spent on the open arms (OA time %) (A and C) and the percentage of open arms
entries (OA entries %) (B and D) in the elevated plus maze test. Data are expressed as mean ± S.E.M. with 12 rats per group.
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1.76. Open Arm Entries: Control + Saline group 1.58 ±
0.31; Control + ZIP group 1.67 ± 0.26; SPS + Saline group
0.83 ± 0.17; SPS + ZIP group 1.25 ± 0.22). Post hoc ana-
lysis revealed that ZIP treatment significantly increased
the percentage of open arm time and the percentage of
open arm entries in the SPS + ZIP group compared with
the SPS + Saline group (p < 0.001, respectively).
Changes in the expression of PKMζ and PKCζ
The PKCζ, PKMζ and GAPDH proteins were detected at
75, 55 and 36 kDa, respectively (Figure 5A), and the
mean values of the band densities of the control group
were set as 100%. The data were expressed as nor-
malized ODs (Figure 5B). One-way ANOVA showed sig-
nificant differences in the OD value of PKCζ (F (2, 33) =
4.05, p = 0.027). Post hoc comparison revealed that the
OD value of the PKCζ bands had a significant increase
at 7 day in the SPS groups compared with the control
group (p = 0.021), while there was no difference betweenSPS 14d and the control groups (p = 0.263). The OD
value of the PKMζ bands had a significant increase at 7
and 14 days in the SPS groups compared with the con-
trol group (p < 0.05, one-way ANOVA). There were also
significant differences in the OD value of PKMζ (F (2,
33) = 68.018, p < 0.001). Post hoc comparison revealed
that both the SPS 7d group and the SPS 14d group had
a significant increase in the OD value than the control
group (p < 0.001, respectively).
To further confirm the changes in PKMζ expression
caused by SPS exposure, Real-time RT-PCR analysis was
performed (Figure 6). One-way ANOVA showed signifi-
cant differences in the mRNA expression of PKMζ (F (2,
15) = 29.99, p < 0.001). Post hoc comparison revealed
that both the SPS 7d group and the SPS 14d group had
a higher mRNA level than the control group (p < 0.001,
respectively). In the analysis of PKCζ, one-way ANOVA
showed significant differences in the mRNA expression
of PKCζ (F (2, 15) = 5.503, p = 0.016). Post hoc compari-
son revealed that the SPS 7d group had a higher mRNA
Figure 6 Effect of SPS on the PKMζ and PKCζ mRNA expression
in the hippocampus. Data are expressed as mean ± S.E.M. with 6 rats
per group. Results were compared with GAPDH as the internal control.
The relative mRNA levels were represented as the ratios by comparing
the expression of each group with that of the Control group.
Figure 5 Western blot analysis demonstrating the expression
of PKMζ and PKCζ proteins in the hippocampus of the control,
SPS 7d and SPS 14d groups. GAPDH was used as a loading
control (A). The relative levels are presented as the mean ± S.E.M.
(B), n = 6 per group.
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no difference between SPS 14d and the control groups
(p = 0.15).
Discussion
In this study, rats subjected to SPS showed significantly
enhanced depressive or anxiety-like behavior when re-
stressed by re-exposure to the forced swim component
of SPS. Meanwhile, there were significantly increased
PKMζ levels compared with the control group. The add-
itional FST at the end of SPS quiescent period differed
from the conventionally used SPS protocol. After SPS,
rats treated with ZIP prior to the trauma-related stressor
displayed significantly shorter immobility time in the
forced swim test compared with the vehicle group.
The inactivation of PKMζ with intra-hippocampal ZIP
infusions effectively reduced PTSD-related behavioral
abnormalities.
Although recent research in PTSD has yielded a number
of important data, many issues concerning the etiopatho-
genisis remain elusive. In this context, the establishment
of an appropriate animal model of PTSD is a prerequisite
for better understanding of its mechanisms and the ex-
ploitation of more effective therapeutic intervention. Early
animal models, like inescapable shock-learned helpless-
ness models, though having good face validity, failed to re-
produce the HPA axis changes characteristic of PTSD
[17]. Although no ideal animal model of PTSD has been
established to date, the single prolonged stress paradigm,
proposed by Liberzon et al., has been widely accepted as a
putative model for PTSD. SPS model successfully re-
plicates several memory impairments found in PTSD pa-
tients, as well as pathophysiological characteristics, such
as hypersensitive glucocorticoid feedback. Furthermore,
SPS model has been demonstrated to replicate the inner
neuroendocrine abnormality associated with PTSD [43].
However, studies using classical SPS protocol alone sug-
gested that SPS might not increase anxiety-related beha-
vior [44-48]; neither could it fully mimic the behavioral
alterations without re-exposure to the context that PTSD
patients frequently encountered. Antelman et.al. reported
that stress-re-stress or a time dependent sensitization
(TDS) model was a better paradigm for PTSD [49]. In this
model, a single exposure to stress caused subsequent
sensitization during the re-stress. Similarly, Harvey et al.
used a modified SPS-re-stress paradigm to exhibit en-
hanced anxiety-related behavior by re-stressing rats with
re-exposure to the forced swim component of SPS [44].
Thus, re-exposure to the FST procedure may serve as a
trauma-related cue that enhances anxiety-related reac-
tivity [50]. In the present study, we employed the modified
SPS protocol. Our data showed enhanced depressive or
anxiety-like behavior by re-exposure to the trauma-related
stress, consistent with previous reports [15,17,18,44,46,50].
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tric foot shock at the end of SPS stressors, and observed
an increase in anxiety-related behavior in the EPM [46,47].
Indeed, varient re-stress after SPS exposure has been dem-
onstrated to be sufficient to produce long-lasting enhanced
anxiety-like behavior [50,51].
Multiple lines of evidence indicate that PTSD is asso-
ciated with memory impairment, as well as reduced hip-
pocampal volumes and abnormal hippocampal function
[5]. The hippocampus is responsible for explicit memory
processes and context encoding during fear conditioning
[6,52,53]. Importantly, the hippocampus seems to interact
with the amygdala during the encoding of emotional
memories [54-56], a process that is highly relevant to the
study of PTSD. Hippocampus-related memory modula-
tion in animals can result from intensive stressors or in-
creased stress-associated hormones [5]. Extensive research
has shown that stress is a potent modulator of learning
and memory processes–including impairing and facilita-
ting effects [57], which is possibly involved in the develop-
ment of PTSD.
In the past few years, protein kinase M zeta, which is
expressed exclusively in neural tissue and enriched in the
forebrain, has attracted intense interest for its putative
role in memory maintenance. It lacks pseudosubstrate-
dependent inhibition [58,59]. This potential autonomous
activity suggests that PKMζ might be an important player
in LTP maintenance. Indeed, its activation enhances and
its inhibition disrupts previously stored memories [60]. A
wealth of subsequent work has indicated that inhibition of
PKMζ disrupts long-term memory in a wide range of
brain organs, including the hippocampus, amygdala, and
insular cortex [60]. The most commonly used inhibitor of
PKMζ is myristoylated zeta-pseudosubstrate inhibitory
peptide, a synthetic peptide that mimics the pseudosub-
strate sequence of PKCζ [25,61], whereas recent work has
raised concerns regarding both the role of PKMζ in mem-
ory maintenance and the specificity of the pharma-
cological agent used to inhibit PKMζ in those studies
[37,62]. These results, however, do not convincingly ex-
clude the possibility that PKMζ is a key player in memory
maintenance [63], and PKMζ still remains largely to be
the target of ZIP infusions [42]. But unfortunately, pre-
vious studies commonly used a scrambled version of ZIP
(Scr-ZIP) as a control peptide, which was demonstrated to
be equally effective at reversing LTP as ZIP, or at least,
weaken the memory to a certain degree [37]. On the con-
trary, the saline condition may be a more appropriate con-
trol for assessing the effects of PKMζ inhibition, as the
animals in saline control routinely exhibited normal reten-
tion of conditioned fear [64].
As a result, the present study used saline injection as
the control treatment, so as to avoid the vague role of Scr-
ZIP. We showed that PKMζ levels were significantlyincreased one day after re-exposure to the trauma-related
stressor. Inactivation of PKMζ with intra-hippocampal
ZIP infusions effectively reduced PTSD-related behavioral
abnormalities 7 days later, consistent with previous studies
that have established the hippocampus as a key structure
in context fear memory storage [65-70]. Alternatively, a
number of contrary studies implied that the dorsal hippo-
campus was not an essential component in context fear
storage [64]. In spite of the current debate, it is important
to point out that the present study places emphasis on the
effect of ZIP on the PTSD-like behavior by SPS exposure,
rather than the erasure of existing memory. To the best of
our knowledge, little literature is concerned with the effect
of ZIP on PTSD symptom. Recently, Cohen et al. injected
ZIP into four different brain structures after predator
scent stress exposure, namely the dorsal hippocampus
(DH), basolateral amygdala, lateral ventricle (LV) and in-
sular cortex (IC) [71]. They reported that inactivation of
PKMζ in the LV or DH within 1 h of exposure effectively
reduced PTSD-like behavioral disruption and trauma cue
response 8 days later, while inactivation of PKMζ 10 days
after exposure had equivalent effects only when adminis-
tered in the IC [71]. However, our results were not quite
consistent with this comprehensive research. The discrep-
ancy might due first to the different PTSD models applied.
The predator scent stress exposure (PSS) model employed
by Cohen et al. was comparatively different from the
present re-stressed SPS model, which involved different
neural circuit and might yield negative impact on the
effectiveness of ZIP. Another possibility existed in the
adoption of different control groups. As mentioned above,
Volk et al. has demonstrated that Scr-ZIP plays a role in
the memory disruption to a certain degree [37]. Therefore,
Scr-ZIP might not be the most appropriate control for
ZIP from the current point of view, which would conse-
quently be hard to make a peer to peer comparison.
In conclusion, the results of the present study demon-
strate that intro-hippocampal administration of ZIP after
re-stressed SPS effectively alleviates depressive and
anxiety-like behavioral abnormalities, and PKMζ might
be involved in the development of PTSD. Continued evi-
dence for the controversial mechanism of ZIP will high-
light its potential use in a wide range of psychiatric
disorders.Competing interest
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